UPC
Universe Pharmaceuticals INC
Price Chart
Latest Quote
$2.91
+0.02 (+0.69%)
Current Price
| Previous Close | $2.89 |
| Open | $2.82 |
| Day High | $3.00 |
| Day Low | $2.78 |
| Volume | 40,594 |
Stock Information
| Shares Outstanding | 632K |
| Total Debt | $9.26M |
| Cash Equivalents | $33.59M |
| Revenue | $17.86M |
| Net Income | $-3.67M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $1.89M |
| EPS (TTM) | $-7.38 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $-22.71M |
| Sales | $17.86M |
| Income | $-3.67M |
| Book/sh | $99.64 |
| Cash/sh | $53.17 |
| Employees | 216 |
Financial Ratios
| Quick Ratio | 3.55 |
| Current Ratio | 4.07 |
| Debt/Eq | 16.49 |
Returns & Margins
| ROA | -2.66% |
| ROE | -7.23% |
| Gross Margin | 35.28% |
| Operating Margin | -6.77% |
| Profit Margin | -20.56% |
Ownership
| Insider Ownership | 11.38% |
| Institutional Ownership | 4.45% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 0.11 |
| P/B | 0.03 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $3.15 |
| SMA50 | $3.08 |
| SMA200 | $3.71 |
| RSI | 51.13 |
| ATR | 0.4058 |
| Shares Float | 487K |
| Short Float | 1.48% |
| Short Ratio | 0.63 |
| Volatility | 1.60 |
| Rel Volume | 0.13 |
Performance History
| Week | -19.83% |
| Month | +12.79% |
| Quarter | +8.99% |
| 6 Months | -19.83% |
| YTD | -30.05% |
| Year | -26.33% |
| 3 Years | -99.91% |
| 5 Years | -99.97% |
| 10 Years | -99.98% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $2.91 | 40,594 |
| 2026-06-16 | $2.89 | 5,341,600 |
| 2026-06-15 | $3.12 | 5,100 |
| 2026-06-12 | $3.24 | 5,100 |
| 2026-06-11 | $3.25 | 23,000 |
| 2026-06-10 | $3.63 | 28,800 |
| 2026-06-09 | $3.37 | 672,800 |
| 2026-06-08 | $3.62 | 36,300 |
| 2026-06-05 | $3.27 | 8,400 |
| 2026-06-04 | $3.33 | 1,200 |
| 2026-06-03 | $3.44 | 4,200 |
| 2026-06-02 | $3.38 | 2,700 |
| 2026-06-01 | $3.37 | 9,700 |
| 2026-05-29 | $3.50 | 28,500 |
| 2026-05-28 | $2.85 | 9,200 |
| 2026-05-27 | $2.85 | 2,100 |
| 2026-05-26 | $2.61 | 1,400 |
| 2026-05-22 | $2.88 | 1,900 |
| 2026-05-21 | $2.69 | 2,100 |
| 2026-05-20 | $2.70 | 8,600 |
| 2026-05-19 | $2.54 | 1,400 |
| 2026-05-18 | $2.58 | 8,500 |
About Universe Pharmaceuticals INC
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu pill; yangxue danggui and qiangli pipa syrup; wuzi yanzong oral, fengtong medicinal, shenrong medicinal, qishe medicinal, fengshitong medicinal, and shiquan dabu medicinal liquor; paracetamol granule for children; and isatis root granule. In addition, the company distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. It primarily serves pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is headquartered in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $11,286,468 | $16,676,426 | $21,680,267 | $17,903,035 |
| Cost Of Revenue | $11,557,563 | $16,952,556 | $21,993,601 | $18,251,815 |
| Total Revenue | $17,858,732 | $23,024,458 | $32,308,735 | $40,143,151 |
| Operating Revenue | $17,858,732 | $23,024,458 | $32,308,735 | $40,143,151 |
| Expenses | ||||
| Interest Expense | $232,041 | $278,172 | $156,788 | $162,400 |
| Total Expenses | $20,774,651 | $31,044,298 | $36,274,836 | $47,162,595 |
| Other Income Expense | $-524,095 | $177,418 | $-204,542 | $87,528 |
| Other Non Operating Income Expenses | $-108,044 | $145,476 | $-235,614 | $48,940 |
| Net Non Operating Interest Income Expense | $-232,041 | $-278,172 | $-156,788 | $-162,400 |
| Interest Expense Non Operating | $232,041 | $278,172 | $156,788 | $162,400 |
| Operating Expense | $9,217,088 | $14,091,742 | $14,281,235 | $28,910,780 |
| Other Operating Expenses | $17,911 | $28,844 | $47,154 | $39,555 |
| Selling And Marketing Expense | $3,796,121 | $6,687,813 | $6,005,565 | $18,304,479 |
| General And Administrative Expense | $4,206,235 | $3,189,232 | $2,995,326 | $2,531,620 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-3,672,055 | $-8,727,298 | $-6,581,024 | $-7,909,638 |
| Net Interest Income | $-232,041 | $-278,172 | $-156,788 | $-162,400 |
| Normalized Income | $-3,190,946 | $-8,727,298 | $-6,581,024 | $-7,909,638 |
| Net Income From Continuing And Discontinued Operation | $-3,672,055 | $-8,727,298 | $-6,581,024 | $-7,909,638 |
| Total Operating Income As Reported | $-2,915,919 | $-8,019,840 | $-3,966,101 | $-7,019,444 |
| Net Income Common Stockholders | $-3,672,055 | $-8,727,298 | $-6,581,024 | $-7,909,638 |
| Net Income | $-3,672,055 | $-8,727,298 | $-6,581,024 | $-7,909,638 |
| Net Income Including Noncontrolling Interests | $-3,672,055 | $-8,727,298 | $-6,581,024 | $-7,909,638 |
| Net Income Continuous Operations | $-3,672,055 | $-8,727,298 | $-6,581,024 | $-7,909,638 |
| Pretax Income | $-3,672,055 | $-8,120,594 | $-4,327,431 | $-7,094,316 |
| Special Income Charges | $-481,109 | $0 | $0 | $-419,353 |
| Earnings From Equity Interest | $65,058 | $31,942 | $31,072 | $38,588 |
| Operating Income | $-2,915,919 | $-8,019,840 | $-3,966,101 | $-7,019,444 |
| Depreciation Amortization Depletion Income Statement | $246,336 | $209,604 | $195,451 | $185,169 |
| Depreciation And Amortization In Income Statement | $246,336 | $209,604 | $195,451 | $185,169 |
| Gross Profit | $6,301,169 | $6,071,902 | $10,315,134 | $21,891,336 |
| Per Share | ||||
| Diluted EPS | - | $-626.96 | $-1089.21 | $-1335.29 |
| Basic EPS | - | $-626.96 | $-1089.21 | $-1335.29 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-2,441,474 | $-7,356,688 | $-3,661,858 | $-6,397,967 |
| Total Unusual Items | $-481,109 | $0 | $0 | $-470,477 |
| Total Unusual Items Excluding Goodwill | $-481,109 | $0 | $0 | $-470,477 |
| Reconciled Depreciation | $517,431 | $485,734 | $508,785 | $533,949 |
| EBITDA (Bullshit earnings) | $-2,922,583 | $-7,356,688 | $-3,661,858 | $-6,397,967 |
| EBIT | $-3,440,014 | $-7,842,422 | $-4,170,643 | $-6,931,916 |
| Diluted NI Availto Com Stockholders | $-3,672,055 | $-8,727,298 | $-6,581,024 | $-7,909,638 |
| Tax Provision | $0 | $606,704 | $2,253,593 | $815,322 |
| Impairment Of Capital Assets | $481,109 | $0 | $0 | - |
| Other Taxes | $392,178 | $246,241 | $179,191 | $205,582 |
| Provision For Doubtful Accounts | $-113,454 | $131,581 | $0 | $419,353 |
| Research And Development | $671,761 | $3,598,427 | $4,858,548 | $7,644,375 |
| Selling General And Administration | $8,002,356 | $9,877,045 | $9,000,891 | $20,836,099 |
| Other Gand A | $2,559,031 | $1,543,867 | $1,488,689 | $1,111,342 |
| Salaries And Wages | $1,647,204 | $1,645,365 | $1,506,637 | $1,420,278 |
| Diluted Average Shares | - | $13,920 | $6,042 | $5,923 |
| Basic Average Shares | - | $13,920 | $6,042 | $5,923 |
| Write Off | - | - | $-439,327 | $419,353 |
| Gain On Sale Of Security | - | - | $38,530 | $-470,477 |
Fetched: 2026-06-16
Balance Sheet (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $55,832,725 | $45,240,063 | $27,821,569 | $46,284,872 |
| Total Assets | $69,303,440 | $67,953,393 | $41,724,482 | $59,539,875 |
| Total Non Current Assets | $15,699,765 | $16,315,609 | $16,454,776 | $18,034,195 |
| Investmentin Financial Assets | $702,346 | $712,494 | $685,307 | $702,890 |
| Goodwill And Other Intangible Assets | $296,785 | $262,878 | $148,584 | $157,451 |
| Other Intangible Assets | $296,785 | $262,878 | $148,584 | $157,451 |
| Current Assets | $53,603,675 | $51,637,784 | $25,269,706 | $41,505,680 |
| Other Current Assets | $39,937 | $852,417 | $37,178 | $1,724,099 |
| Prepaid Assets | $4,592,516 | $1,673,364 | $4,086,077 | $3,531,151 |
| Inventory | $2,193,179 | $1,737,054 | $3,343,266 | $2,206,488 |
| Receivables | $13,186,018 | $17,877,256 | $12,517,938 | $15,183,890 |
| Other Receivables | $177,901 | $4,971,435 | $1,441,352 | - |
| Accounts Receivable | $13,008,117 | $12,905,821 | $11,014,908 | $15,183,890 |
| Allowance For Doubtful Accounts Receivable | $-18,214 | $-135,082 | $0 | $-791,827 |
| Gross Accounts Receivable | $13,026,331 | $13,040,903 | $11,014,908 | $15,975,717 |
| Cash Cash Equivalents And Short Term Investments | $33,592,025 | $29,497,693 | $5,285,247 | $18,860,052 |
| Cash And Cash Equivalents | $33,592,025 | $29,497,693 | $5,285,247 | $5,711,458 |
| Cash Financial | $33,592,025 | $29,497,693 | $5,285,247 | $5,711,458 |
| Non Current Prepaid Assets | - | $0 | $35,864 | $2,249,248 |
| Non Current Deferred Assets | - | $0 | $599,078 | $1,347,672 |
| Non Current Deferred Taxes Assets | - | $0 | $599,078 | $1,347,672 |
| Current Deferred Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $9,256,919 | $7,994,186 | $5,482,456 | $3,936,184 |
| Current Debt And Capital Lease Obligation | $9,256,919 | $5,856,703 | $5,482,456 | $3,936,184 |
| Current Debt | $9,256,919 | $5,856,703 | $5,482,456 | $3,936,184 |
| Other Current Borrowings | $2,107,038 | $5,856,703 | $5,482,456 | - |
| Long Term Debt And Capital Lease Obligation | - | $2,137,483 | - | - |
| Long Term Debt | - | $2,137,483 | - | - |
| Net Debt | - | - | $197,209 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $13,173,930 | $22,450,452 | $13,754,329 | $13,097,552 |
| Total Non Current Liabilities Net Minority Interest | $0 | $2,137,483 | $0 | $0 |
| Current Liabilities | $13,173,930 | $20,312,969 | $13,754,329 | $13,097,552 |
| Current Deferred Liabilities | $40,708 | $0 | - | - |
| Payables And Accrued Expenses | $3,876,303 | $14,456,266 | $8,271,873 | $9,161,368 |
| Payables | $3,613,682 | $14,103,412 | $5,560,137 | $6,622,006 |
| Other Payable | $856,572 | $1,266,885 | - | - |
| Total Tax Payable | $640,780 | $1,021,181 | $434,758 | $167,350 |
| Accounts Payable | $1,669,785 | $4,914,762 | $4,585,283 | $3,075,393 |
| Income Tax Payable | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $56,129,510 | $45,502,941 | $27,970,153 | $46,442,323 |
| Total Equity Gross Minority Interest | $56,129,510 | $45,502,941 | $27,970,153 | $46,442,323 |
| Stockholders Equity | $56,129,510 | $45,502,941 | $27,970,153 | $46,442,323 |
| Gains Losses Not Affecting Retained Earnings | $626,013 | $1,327,389 | $67,295 | $772,830 |
| Other Equity Adjustments | $626,013 | $1,327,389 | $67,295 | $772,830 |
| Retained Earnings | $-13,843,623 | $-10,171,568 | $-1,444,270 | $16,322,365 |
| Other | ||||
| Ordinary Shares Number | $563,338 | $39,409 | $6,076 | $6,041 |
| Share Issued | $563,338 | $39,409 | $6,076 | $6,041 |
| Tangible Book Value | $55,832,725 | $45,240,063 | $27,821,569 | $46,284,872 |
| Invested Capital | $65,386,429 | $53,497,127 | $33,452,609 | $50,378,507 |
| Working Capital | $40,429,745 | $31,324,815 | $11,515,377 | $28,408,128 |
| Total Capitalization | $56,129,510 | $47,640,424 | $27,970,153 | $46,442,323 |
| Additional Paid In Capital | $63,009,567 | $53,864,720 | $29,279,155 | $29,279,159 |
| Capital Stock | $6,337,553 | $482,400 | $67,973 | $67,969 |
| Common Stock | $6,337,553 | $482,400 | $67,973 | $67,969 |
| Current Deferred Revenue | $40,708 | $0 | - | - |
| Line Of Credit | $7,149,881 | $5,856,703 | $5,482,456 | $3,936,184 |
| Current Accrued Expenses | $262,621 | $352,854 | $2,711,736 | $2,539,362 |
| Dueto Related Parties Current | $446,545 | $6,900,584 | $540,096 | $3,379,263 |
| Investments And Advances | $702,346 | $712,494 | $685,307 | $702,890 |
| Available For Sale Securities | $702,346 | $712,494 | $685,307 | $702,890 |
| Net PPE | $14,700,634 | $15,340,237 | $14,985,943 | $15,826,182 |
| Accumulated Depreciation | $-6,903,753 | $-6,664,765 | $-6,050,480 | $-5,710,098 |
| Gross PPE | $21,604,387 | $22,005,002 | $21,036,423 | $21,536,280 |
| Construction In Progress | $11,152,539 | $11,808,158 | $11,285,978 | $11,575,544 |
| Machinery Furniture Equipment | $2,867,936 | $2,602,109 | $2,445,509 | $2,468,376 |
| Buildings And Improvements | $7,583,912 | $7,594,735 | $7,304,936 | $7,492,360 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-122,739 | $-124,512 | $-69,746 | $-120,286 |
| Finished Goods | $1,608,488 | $1,141,525 | $2,777,617 | $1,337,731 |
| Raw Materials | $707,430 | $720,041 | $635,395 | $989,043 |
| Other Inventories | - | $-1 | - | - |
| Duefrom Related Parties Current | - | $0 | $61,678 | $0 |
| Treasury Shares Number | - | - | $0 | - |
| Other Short Term Investments | - | - | $13,219,005 | $13,148,594 |
Fetched: 2026-06-16
Cash Flow Statement (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-5,399,506 | $-9,869,772 | $1,072,606 | $-1,395,258 |
| Operating Activities | ||||
| Operating Cash Flow | $-5,052,319 | $-9,506,683 | $1,116,775 | $-1,301,555 |
| Cash Flow From Continuing Operating Activities | $-5,052,319 | $-9,506,683 | $1,116,775 | $-1,301,555 |
| Operating Gains Losses | $2,948 | $3,958 | $114 | $983 |
| Investing Activities | ||||
| Capital Expenditure | $-347,187 | $-363,089 | $-44,169 | $-93,703 |
| Investing Cash Flow | $-341,807 | $-361,285 | $-44,169 | $-3,908,105 |
| Cash Flow From Continuing Investing Activities | $-341,807 | $-361,285 | $-44,169 | $-3,908,105 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $15,000,000 | $24,999,992 | $0 | $0 |
| Financing Cash Flow | $9,726,130 | $33,954,325 | $-1,390,646 | $3,317,943 |
| Cash Flow From Continuing Financing Activities | $9,726,130 | $33,954,325 | $-1,390,646 | $3,317,943 |
| Net Common Stock Issuance | $15,000,000 | $24,999,992 | $0 | $0 |
| Common Stock Issuance | $15,000,000 | $24,999,992 | $0 | $0 |
| Net Other Financing Charges | - | - | $-3,091,977 | $3,317,943 |
| Cash Dividends Paid | - | - | - | $0 |
| Common Stock Dividend Paid | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-15,544,490 | $-8,363,061 | $-10,597,876 | $-4,272,716 |
| Issuance Of Debt | $10,270,620 | $17,317,394 | $9,207,230 | $7,590,659 |
| Interest Paid Supplemental Data | $289,385 | $304,516 | $190,184 | $199,852 |
| Income Tax Paid Supplemental Data | $0 | $0 | $863,800 | $2,748,629 |
| End Cash Position | $33,592,025 | $29,497,693 | $5,285,247 | $5,711,458 |
| Beginning Cash Position | $29,497,693 | $5,285,247 | $5,711,458 | $8,077,908 |
| Effect Of Exchange Rate Changes | $-237,672 | $126,089 | $-108,171 | $-474,733 |
| Changes In Cash | $4,332,004 | $24,086,357 | $-318,040 | $-1,891,717 |
| Net Issuance Payments Of Debt | $-5,273,870 | $8,954,333 | $-1,390,646 | $3,317,943 |
| Net Long Term Debt Issuance | $-5,273,870 | $8,954,333 | $-1,390,646 | $3,317,943 |
| Long Term Debt Payments | $-15,544,490 | $-8,363,061 | $-10,597,876 | $-4,272,716 |
| Long Term Debt Issuance | $10,270,620 | $17,317,394 | $9,207,230 | $7,590,659 |
| Net Intangibles Purchase And Sale | $-80,416 | $-117,291 | $0 | $0 |
| Purchase Of Intangibles | $-80,416 | $-117,291 | $0 | $0 |
| Net PPE Purchase And Sale | $-261,391 | $-243,994 | $-44,169 | $-93,180 |
| Sale Of PPE | $5,380 | $1,804 | $0 | $523 |
| Purchase Of PPE | $-266,771 | $-245,798 | $-44,169 | $-93,703 |
| Change In Working Capital | $-2,268,298 | $-2,058,013 | $5,670,410 | $6,599,752 |
| Change In Other Working Capital | $40,180 | - | $-947,964 | - |
| Change In Payables And Accrued Expense | $-4,248,749 | $-469,034 | $2,166,380 | $-505,344 |
| Change In Accrued Expense | $-85,440 | $-31,467 | $170,049 | $2,318,474 |
| Change In Payable | $-4,163,309 | $-437,567 | $1,996,331 | $-2,823,818 |
| Change In Account Payable | $-3,132,705 | $143,747 | $1,641,426 | $-1,919,691 |
| Change In Tax Payable | $-324,530 | $554,425 | $280,939 | $-904,127 |
| Change In Income Tax Payable | $-324,530 | $554,425 | $280,939 | $-904,127 |
| Change In Prepaid Assets | $-715,727 | $-1,526,265 | $526,131 | $9,644,874 |
| Change In Inventory | $-474,633 | $1,643,131 | $-1,183,823 | $16,586 |
| Change In Receivables | $3,130,631 | $-1,705,845 | $5,109,686 | $-2,556,364 |
| Changes In Account Receivables | $-168,958 | $-1,547,834 | $4,718,118 | $-1,526,243 |
| Provisionand Write Offof Assets | $-113,454 | $182,232 | $-49,166 | $15,774 |
| Asset Impairment Charge | $481,109 | $0 | $0 | - |
| Deferred Tax | $0 | $606,704 | $1,567,656 | $-542,375 |
| Deferred Income Tax | $0 | $606,704 | $1,567,656 | $-542,375 |
| Depreciation Amortization Depletion | $517,431 | $485,734 | $508,785 | $533,949 |
| Depreciation And Amortization | $517,431 | $485,734 | $508,785 | $533,949 |
| Gain Loss On Sale Of PPE | $2,948 | $3,958 | $114 | $983 |
| Net Income From Continuing Operations | $-3,672,055 | $-8,727,298 | $-6,581,024 | $-7,909,638 |
| Net Business Purchase And Sale | - | $0 | $0 | $-3,814,925 |
| Purchase Of Business | - | $0 | $0 | $-3,814,925 |
| Net Short Term Debt Issuance | - | - | $1,701,331 | $0 |
| Short Term Debt Payments | - | - | $-3,969,773 | $-4,272,716 |
| Short Term Debt Issuance | - | - | $5,671,104 | $4,272,716 |
| Net Investment Purchase And Sale | - | - | $0 | $0 |
| Sale Of Investment | - | - | $0 | $0 |
| Purchase Of Investment | - | - | $0 | $0 |
| Gain Loss On Investment Securities | - | - | $-38,530 | $470,477 |
Fetched: 2026-06-16